Skip to content
S5667Senate2021-2022 SessionSame asA3253

Track Diabetes Test Suppliers

Official title

“Relates to designated suppliers and authorized distributors of nonprescription blood glucose self-testing equipment, devices and supplies”

Sponsor Neil D. BreslinSD-44Affects Education
Status
In Senate Committee
Higher Education
Impact
4/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Higher Education

What's happening

This bill requires manufacturers to report authorized suppliers of nonprescription blood glucose testing products, and prohibits pharmacists from dispensing or claiming reimbursement for such products from unauthorized sources.

Why it matters

  1. Increases transparency and oversight. by requiring manufacturers to publicly identify which suppliers and distributors are authorized to sell nonprescription blood glucose self-testing products, helping prevent gray-market or counterfeit products from entering the supply chain.

  2. Holds pharmacists accountable. for ensuring that the products they dispense and seek reimbursement for are sourced from legitimate, manufacturer-approved suppliers—potentially reducing the risk of patients receiving unreliable or unsafe testing devices.

  3. May affect patient access and pharmacy operations. , as pharmacists will need to check supplier lists and ensure compliance, possibly limiting the number of vendors they can use and increasing administrative burdens.

  4. Could help control insurance and government spending. by preventing fraudulent or ineligible reimbursement claims for products sourced through unauthorized channels, thus protecting payors and ultimately consumers from higher costs due to fraud or substandard products.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Track Diabetes Test Suppliers

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Neil D. Breslin

Senator · Senate District 44

Chair, Insurance

No co-sponsors yet.

History

  1. Referred to higher education
  2. Referred to higher education

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A3253Assembly

Track Diabetes Test Suppliers

In Assembly Committee · Higher Education · Sponsor John T. McDonald III

Impact 4 · Low0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

5667

2021-2022 Regular Sessions

IN SENATE

March 15, 2021

Introduced by Sen. BRESLIN -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education

AN ACT to amend the education law, in relation to designated suppliers and authorized distributors of nonprescription blood glucose selftesting equipment, devices and supplies

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The education law is amended by adding a new section 6808-c to read as follows:

§ 6808-c. Suppliers and authorized distributors of nonprescription blood glucose self-testing equipment, devices and supplies. 1. As used in this section, "nonprescription blood glucose self-testing equipment, devices and supplies" means blood glucose monitors, continuous glucose monitors (CGM), blood glucose test strips, lancet devices and lancets, glucose control solutions for checking the accuracy of testing equipment and test strips, supply allowance for therapeutic continuous glucose monitors (CGM), including all supplies and accessories for use in the treatment of prediabetic or diabetic individuals that may be sold without a prescription and are labeled for use by the consumer in accordance with the requirements of the laws and rules of this state and the federal government.

2. Within one hundred eighty days of the effective date of this section, each manufacturer of nonprescription blood glucose self-testing equipment, devices and supplies shall submit to the state board of pharmacy a comprehensive list of designated suppliers and authorized distributors of nonprescription blood glucose self-testing equipment, devices and supplies. Such manufacturers shall update the state board of pharmacy when there are any changes to the list of designated suppliers and authorized distributors. Within ninety days of receiving that information, such board shall post the names of designated suppliers and authorized distributors on the department's website.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD01887-01-1

S. 5667 2

3. It shall be unprofessional conduct for a pharmacist to:

a. dispense nonprescription blood glucose self-testing equipment, devices and supplies received from a person or entity that the pharmacist knew or reasonably should have known was not a manufacturer's designated supplier or authorized distributor; or

b. submit a reimbursement claim for nonprescription blood glucose self-testing equipment, devices and supplies to a pharmaceutical benefit manager, health insurer, government agency, or other third-party payor when the pharmacist knew or reasonably should have known that the diabetes test device was not purchased either directly from the manufacturer or from the nonprescription blood glucose self-testing equipment, devices and supplies manufacturer's designated supplier or authorized distributor.

§ 2. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the education law, in relation to designated suppliers and authorized distributors of nonprescription blood glucose self-test- ing equipment, devices and supplies

Summary of specific provisions

Section 1 adds a new section 6808-c to create a definition for nonpres- cription blood glucose self-testing equipment, devices, and supplies and requires manufacturers to submit a list of designated supplies and authorized distributors to the New York State Board of Pharmacy to post publicly on the NYS Education Department website and to keep the list updated as changes occur. The new section also finds that it shall be unprofessional conduct for a pharmacist to dispense nonprescription blood glucose self-testing equipment, devices, and supplies that they knew or reasonably should have known are not from a designated supplier or authorized distributor or to submit a reimbursement claim for such nonprescription blood glucose self-testing equipment, devices, and supplies if the pharmacist knew or reasonably should have known that the device was not purchased from a designated supplier or authorized distributor.

Section 2 provides for an immediate effective date.

Justification

When using diabetes testing devices, supplies, and equipment (i.e. Blood Glucose Testing Supplies (BGTS) or Continuous Glucose Monitoring (CGM)), patients make therapeutic decisions based on prescribers proto- cols to manage diabetes. These decisions result in changes in dosing of insulin by as little as 1-2 units of insulin and an incorrect adjustment can lead to hypoglycemia or hyperglycemia, negatively impacting a patient's health. Consistency of product is crucial in overall diabetes management.

It has been widely reported regarding the growth of the illicit market for diabetes testing supplies and equipment, especially glucose strips. The Albany Times Union in 2012 cited a growing diabetic population fuel- ing the underground market. In April 2019, the U.S. Food and Drug Admin- istration issued a safety alert warning that sellers are marketing pre- owned test strips or test strips not authorized for sale in the United State leading to inaccurate test results, infections, and increased risk of serious patient injury, including death.

This bill seeks to address this issue by providing information regarding authorized distributors and designated suppliers on the NYS Education Department website to allow ease of access to the information and to provide penalties in the event that a pharmacist chooses to sell diabetes testing equipment that is not from a designated supplier or authorized distributor. This is an important consumer protection and safety issue that will protect those who are managing diabetes, an ever growing population.

Prior legislative history

2019-2020: S.5403 Referred to Higher Education

Fiscal implications

None.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.